Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC

Clinical trial NCT04610658 · TERMINATED

Trial details

NCT number: NCT04610658
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Small-cell Lung Cancer Relapsed Small Cell Lung Cancer Recurrent Small Cell Lung Cancer

Start date: 2020-11-23
Primary completion: 2023-03-24
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.